172 related articles for article (PubMed ID: 34754077)
61. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
62. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
63. Anticancer effect of 2,7-dihydroxy-3-methylanthraquinone on human gastric cancer SGC-7901 cells in vitro and in vivo.
Zhu H; Zheng Z; Zhang J; Liu X; Liu Y; Yang W; Liu Y; Zhang T; Zhao Y; Liu Y; Su X; Gu X
Pharm Biol; 2016; 54(2):285-92. PubMed ID: 25853970
[TBL] [Abstract][Full Text] [Related]
64. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.
Ling Z; Long X; Li J; Feng M
Genes Cells; 2020 Jul; 25(7):466-474. PubMed ID: 32281175
[TBL] [Abstract][Full Text] [Related]
65. Ginkgolic Acid Suppresses Nasopharyngeal Carcinoma Growth by Inducing Apoptosis and Inhibiting
Xiao Y; Li F; Zheng A; Chen Q; Chen F; Cheng X; Tao Z
J Med Food; 2021 Aug; 24(8):806-816. PubMed ID: 34382859
[TBL] [Abstract][Full Text] [Related]
66. Taurine induces upregulation of p53 and Beclin1 and has antitumor effect in human nasopharyngeal carcinoma cells in vitro and in vivo.
Okano M; He F; Ma N; Kobayashi H; Oikawa S; Nishimura K; Tawara I; Murata M
Acta Histochem; 2023 Jan; 125(1):151978. PubMed ID: 36470150
[TBL] [Abstract][Full Text] [Related]
67. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
Liu X; Lv XB; Wang XP; Sang Y; Xu S; Hu K; Wu M; Liang Y; Liu P; Tang J; Lu WH; Feng QS; Chen LZ; Qian CN; Bei JX; Kang T; Zeng YX
Cell Cycle; 2012 Jul; 11(13):2495-506. PubMed ID: 22739938
[TBL] [Abstract][Full Text] [Related]
68. LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.
Chen X; Wu G; Qing J; Li C; Chen X; Shen J
J Clin Lab Anal; 2022 May; 36(5):e24424. PubMed ID: 35421264
[TBL] [Abstract][Full Text] [Related]
69. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
[No Abstract] [Full Text] [Related]
70. STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion.
Ouyang Y; Jin YB; Chen XP; Zhang GY; Mao SL; Ling F; Luo W
Neoplasma; 2020 Jan; 67(1):37-45. PubMed ID: 31607137
[TBL] [Abstract][Full Text] [Related]
71. In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma.
Xue C; Tian Y; Zhang J; Zhao Y; Zhan J; Fang W; Zhang L
Drug Des Devel Ther; 2016; 10():1299-306. PubMed ID: 27099475
[TBL] [Abstract][Full Text] [Related]
72. Increased SHP-1 expression results in radioresistance, inhibition of cellular senescence, and cell cycle redistribution in nasopharyngeal carcinoma cells.
Sun Z; Pan X; Zou Z; Ding Q; Wu G; Peng G
Radiat Oncol; 2015 Jul; 10():152. PubMed ID: 26215037
[TBL] [Abstract][Full Text] [Related]
73. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma.
Shi C; Guan Y; Zeng L; Liu G; Zhu Y; Xu H; Lu Y; Liu J; Guo J; Feng X; Zhao X; Jiang W; Li G; Li G; Dai Y; Jin F; Li W; Zhou W
Int J Oncol; 2018 Sep; 53(3):1138-1148. PubMed ID: 29956730
[TBL] [Abstract][Full Text] [Related]
74. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
[TBL] [Abstract][Full Text] [Related]
75. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
[TBL] [Abstract][Full Text] [Related]
76. Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma.
Wong CH; Ma BBY; Hui CWC; Lo KW; Hui EP; Chan ATC
Sci Rep; 2018 May; 8(1):8010. PubMed ID: 29789630
[TBL] [Abstract][Full Text] [Related]
77. Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest.
Liu Q; Guan X; Lv J; Li X; Wang Y; Li L
Sci Rep; 2015 Jan; 5():7626. PubMed ID: 25557837
[TBL] [Abstract][Full Text] [Related]
78. Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin.
Mishra K; Dash AP; Swain BK; Dey N
Malar J; 2009 Feb; 8():26. PubMed ID: 19216765
[TBL] [Abstract][Full Text] [Related]
79. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
80. PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
Chen H; Wei L; Luo M; Wang X; Zhan Y; Mao Y; Huang C; Li J; Lu H
Environ Toxicol; 2021 Nov; 36(11):2291-2301. PubMed ID: 34363436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
